Skip to main content
Toggle navigation
Login
Search
Home
ICPE 2023 Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
U
267
Unbalanced microbial genomic sequences from East Africa limits global surveillance for antimicrobial resistance in non-typhoidal Salmonella
Favorite
067
Uncovering the Skin Reactions: Retrospectively Analyzing the Adverse Drug Reactions Related to Skin & Subcutaneous Tissues disorders
Favorite
232
Understanding Data Source Characteristics Triggering Heterogeneity When Pooling RWD Sources in Pharmacoepidemiological Studies
Favorite
148
Understanding the journey and complications in patients with type 2 diabetes from the US and the UK: an OMOP-based data network analysis
Favorite
241
Unlocking the patient journey: comparing machine learning (ML) based natural language processing (NLP) and expert abstraction in understanding treatment patterns
Favorite
157
Unveiling the impact of Digital Health Interventions in Coronary Heart Disease: A Systematic review and Meta-analysis
Favorite
077
Updated Real-World Safety of the Pfizer-BioNTech COVID-19 Vaccine in Pregnancy: Data from the Organization of Teratology Information Specialists (OTIS) Pregnancy Registry
Favorite
198
Urban-Rural Differences in Mortality among Patients Receiving Buprenorphine for Opioid Use Disorder Treatment in Kentucky
Favorite
092
Ursodeoxycholic acid may be a new protective factor for severe COVID-19 outcomes – evidence from a nationwide Swedish register-based cohort study within the SCIFI-PEARL project
Favorite
A47
Use and contribution of registries in registry-based randomized clinical trials: a review
Favorite
193
Use of a Clustering Algorithm for Treatment Sequences (TAK®) as a Pre-processing Step to Explanatory and Predictive Models
Favorite
C15
Use of A Wearable Activity Tracker to Assess Differences in REM Sleep Duration Among Adolescents With and Without Depression
Favorite
A48
Use of Antibiotics in the ‘Watch’ category of the WHO AWaRe classification in Europe: a DARWIN-EU® multinational network cohort study (EUPAS103381)
Favorite
135
Use Of Baclofen For The Treatment Of Alcohol Use Disorders Between 2014 And 2021 In France
Favorite
002
Use of Bibliometrics and Altmetrics in Research Impact Assessment of the Canadian Network for Observational Drug Effect Studies: Preliminary Observations
Favorite
B15
Use of Different Antihypertensive Drugs and Risk of Intradialytic Hypotension in Patients Undergoing Hemodialysis
Favorite
014
Use of intra-articular corticosteroid injections among osteoarthritis patients in UK general practice
Favorite
071
Use of Janssen Ad26.COV2.S COVID-19 Vaccine (JCOVDEN) and mRNA COVID-19 Vaccines in Four Large US National Insurers
Favorite
090
Use of Medication for Gastroesophageal Reflux During Pregnancy and Adverse Birth Outcomes
Favorite
124
Use of multiple sclerosis disease-modifying therapies during pregnancy in France from 2010 to 2021
Favorite
205
Use of the web to promote antimicrobial stewardship–implementation of national AMR action plans, 2021
Favorite
159
Use of US Health Insurance Claims Data to Determine Cause of Death
Favorite
090
Use of Very Low-Dose Vaginal Estrogens Among Postmenopausal Women in the US
Favorite
132
Using a causal framework and electronic health record data to infer the effects of antidepressant exposure in pregnancy
Favorite
141
Using administrative data to understand substance misuse patterns in understudied populations: A child welfare sample
Favorite
263
Using claims data to identify the exact indication of use for biological drugs approved for Immune-Mediated Inflammatory Diseases: The VALORE project experience
Favorite
C08
Using Historical RCT Controls to Contextualize Necessity of Unblinding of Serious Adverse Events and Adverse Events of Special Interest – Conceptual Framework and Database Development
Favorite
184
Using linkage between routinely and prospectively collected data to improve disease definitions
Favorite
253
Using Linked Registry–Electronic Health Records to Examine Amputations following Peripheral Vascular Intervention
Favorite
242
Using Real World Data to Inform Clinical Trial Design
Favorite
197
Using Real-World Data to Evaluate Comparative Effectiveness Cohorts of Azithromycin Relative to Roflumilast in Individuals with Uncontrolled Chronic Obstructive Pulmonary Disease
Favorite
A08
Using Real-World Data to Support Clinical Trial Diversity and Inclusion Strategies: A Case Study of Cancer of the Cervix
Favorite
191
Using real-world general practitioner data to study the diagnosis and management of dementia: rationale and design
Favorite
278
Utilisation and safety of Glycopyrronium Bromide 1mg/5ml oral solution for sialorrhoea in the paediatric population in the UK: Interim results from a non-interventional post authorisation safety study
Favorite
177
Utilisation and Safety of IV Bolus Formulation of Akis® for use in the Prevention and Treatment of Post-operative Pain in the UK Secondary Setting
Favorite
047
Utilisation patterns of the COVID-19 mRNA vaccine (Comirnaty®) from the VAC4EU active safety surveillance study in five European countries
Favorite
B30
Utility of Healthcare Professional (HCP) Surveys for Evaluating the Effectiveness of Additional Risk Minimization Measures (aRMMs): Experience from an HCP Survey Assessing the Effectiveness of aRMMs for Xeljanz® in Europe
Favorite
066
Utility of Procedure Codes in Identifying Use of Long-Acting Cabotegravir in Administrative Claims Data
Favorite
179
Utilization and evaluation of Drug therapy usage among neonates admitted to Neonatal Intensive Care Unit (NICU)
Favorite
030
Utilization and patient characteristics for the originator and biosimilar trastuzumab products in the United States
Favorite
271
Utilization of a Hybrid Data Environment Linking Registry, Claims and EHR to Identify Myocarditis Patients
Favorite
051
Utilization of antidepressants in patients with chronic kidney disease: A nationwide cohort study
Favorite
A22
Utilization of antihypertensives before, during, and after pregnancy
Favorite
A32
Utilization of beta-blockers among the pediatric population in the United States: a study in the FDA’s Sentinel System from 2008 to 2022
Favorite
181
Utilization of Comprehensive Metabolic Panels in Regular Patient Management: Investigation of Patient Follow-up Based on Abnormal Test results in a Claims Laboratory Test Result Database
Favorite
C44
Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Children in Switzerland: a Descriptive Study Using Swiss Claims Data
Favorite
017
Utilization of Gonadotropin-Releasing Hormone Agonist Products in Adolescents
Favorite
095
Utilization of prescribed drugs in pregnancy between 2015 and 2021 in Switzerland: A retrospective analysis of Swiss healthcare claims data
Favorite
111
Utilization of Telemedicine and antibiotic dispensing before and during the COVID-19 pandemic
Favorite
A23
Utilization patterns of Antidepressants in pregnant women: An interrupted time series analysis
Favorite
180
Utilizing Real World Data from a National Database of Living Donor Kidney Transplants to identify Targeted Subgroups for Planned Intervention Trials to prolong graft survival
Favorite
